Open AccessHome treatment of type VI mucopolysaccharidosis (Maroteaux‐Lamy syndrome) an alternative at this time of COVID‐19 pandemic: A case in Peru
Author(s) -
Cortez Miranda Jenny Lucy,
Blacido Trujillo Lincoln,
Liendo Chocano María Elena
Publication year - 2020
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3420
Subject(s) - medicine , mucopolysaccharidosis , enzyme replacement therapy , covid-19 , pandemic , intensive care medicine , mucopolysaccharidosis type ii , pediatrics , virology , disease , outbreak , infectious disease (medical specialty)
We report a patient with mucopolysaccharidosis type VI, on long‐term enzyme replacement home therapy. Results support the efficacy and safety benefits, with additional advantage of home therapy to minimize the risk of community‐transmitted infections.